[1] WANG L, XU X, ZHANG M, et al. Prevalence of Chronic Kidney Disease in China: Results From the Sixth China Chronic Disease and Risk Factor Surveillance [J]. JAMA Intern Med, 2023, 183(4): 298-310.
[2] ABDEL-HAMEED A R, AHMED M F, ELSANTAWY A A, et al. Prevalence, risk factors and impact of proteinuria-associated hypomagnesemia in chronic kidney disease patients: cross-sectional study [J]. The Egyptian Journal of Internal Medicine, 2022, 34(1).
[3] KEMP J A, BRITTO I K, RIBEIRO M, et al. Serum Magnesium Levels in Patients with Chronic Kidney Disease: Is There a Relationship with Inflammation Status? [J]. Biol Trace Elem Res, 2023.
[4] YU L, ZU Y, LU J, et al. Higher Serum Magnesium Is a Survival Advantage in Maintenance Hemodialysis Patients [J]. Blood Purif, 2023, 52(4): 382-91.
[5] APELL H-J, HITZLER T, SCHREIBER G. Modulation of the Na,K-ATPase by Magnesium Ions [J]. Biochemistry, 2017, 56(7): 1005-16.
[6] MATHEW A A, PANONNUMMAL R. 'Magnesium'-the master cation-as a drug-possibilities and evidences [J]. Biometals, 2021, 34(5): 955-86.
[7] MASSY Z A, NISTOR I, APETRII M, et al. Magnesium-based interventions for normal kidney function and chronic kidney disease [J]. Magnes Res, 2016, 29(4): 126-40.
[8] HSIAO P-J, LIAO C-Y, KAO Y-H, et al. Comparison of fractional excretion of electrolytes in patients at different stages of chronic kidney disease: A cross-sectional study [J]. Medicine (Baltimore), 2020, 99(2): e18709.
[9] SAKAGUCHI Y, IWATANI H, HAMANO T, et al. Magnesium modifies the association between serum phosphate and the risk of progression to end-stage kidney disease in patients with non-diabetic chronic kidney disease [J]. Kidney Int, 2015, 88(4): 833-42.
[10] SAKAGUCHI Y, HAMANO T, MATSUI I, et al. Low magnesium diet aggravates phosphate-induced kidney injury [J]. Nephrol Dial Transplant, 2019, 34(8): 1310-9.
[11] DIAZ-TOCADOS J M, PERALTA-RAMIREZ A, RODRíGUEZ-ORTIZ M E, et al. Dietary magnesium supplementation prevents and reverses vascular and soft tissue calcifications in uremic rats [J]. Kidney Int, 2017, 92(5): 1084-99.
[12] PABLA N, DONG Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies [J]. Kidney Int, 2008, 73(9).
[13] VAN LAECKE S, NAGLER E V, VERBEKE F, et al. Hypomagnesemia and the risk of death and GFR decline in chronic kidney disease [J]. Am J Med, 2013, 126(9): 825-31.
[14] PHAM P C T, PHAM P M T, PHAM P A T, et al. Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type 2 [J]. Clin Nephrol, 2005, 63(6): 429-36.
[15] SAKAGUCHI Y, SHOJI T, HAYASHI T, et al. Hypomagnesemia in type 2 diabetic nephropathy: a novel predictor of end-stage renal disease [J]. Diabetes Care, 2012, 35(7): 1591-7.
[16] FARHADNEJAD H, ASGHARI G, MIRMIRAN P, et al. Micronutrient Intakes and Incidence of Chronic Kidney Disease in Adults: Tehran Lipid and Glucose Study [J]. Nutrients, 2016, 8(4): 217.
[17] MOHTASHAMIAN A, MOZAFFARI-RAD N, SOLEIMANI A, et al. Dietary Magnesium Intake and Proteinuria: Is There a Relationship? [J]. Biol Trace Elem Res, 2023.
[18] NA D, TAO G, SHU-YING L, et al. Association between hypomagnesemia and severity of primary hyperparathyroidism: a retrospective study [J]. BMC Endocr Disord, 2021, 21(1): 170.
[19] OHYA M, NEGI S, SAKAGUCHI T, et al. Significance of serum magnesium as an independent correlative factor on the parathyroid hormone level in uremic patients [J]. J Clin Endocrinol Metab, 2014, 99(10): 3873-8.
[20] WEI M, ESBAEI K, BARGMAN J M, et al. Inverse correlation between serum magnesium and parathyroid hormone in peritoneal dialysis patients: a contributing factor to adynamic bone disease? [J]. Int Urol Nephrol, 2006, 38(2): 317-22.
[21] SHAMSPOUR N, MOLAHOSEINI M, AZMANDIAN J, et al. To evaluate the relationship between serum magnesium and parathyroid hormone levels in peritoneal dialysis and hemodialysis patients [J]. Int Urol Nephrol, 2023, 55(5): 1321-7.
[22] GUO G, ZHOU J, XU T, et al. Effect of Magnesium Supplementation on Chronic Kidney Disease-Mineral and Bone Disorder in Hemodialysis Patients: A Meta-Analysis of Randomized Controlled Trials [J]. J Ren Nutr, 2022, 32(1): 102-11.
[23] ITO M, YAMAGUCHI M, KATSUNO T, et al. Association between serum magnesium levels and abdominal aorta calcification in patients with pre-dialysis chronic kidney disease stage 5 [J]. PLoS One, 2021, 16(6): e0253592.
[24] SHIIZAKI K, TSUBOUCHI A, MIURA Y, et al. Calcium phosphate microcrystals in the renal tubular fluid accelerate chronic kidney disease progression [J]. J Clin Invest, 2021, 131(16).
[25] MATSUZAKI H, KATSUMATA S, MAEDA Y, et al. Changes in circulating levels of fibroblast growth factor 23 induced by short-term dietary magnesium deficiency in rats [J]. Magnes Res, 2016, 29(2): 48-54.
[26] VAN DEN BROEK D H N, CHANG Y-M, ELLIOTT J, et al. Prognostic importance of plasma total magnesium in a cohort of cats with azotemic chronic kidney disease [J]. J Vet Intern Med, 2018, 32(4): 1359-71.
[27] GRIGORE T V, ZUIDSCHERWOUDE M, WITASP A, et al. Fibroblast growth factor 23 is independently associated with renal magnesium handling in patients with chronic kidney disease [J]. Front Endocrinol (Lausanne), 2022, 13: 1046392.
[28] IGUCHI A, WATANABE Y, IINO N, et al. Serum magnesium concentration is inversely associated with fibroblast growth factor 23 in haemodialysis patients [J]. Nephrology (Carlton), 2014, 19(11): 667-71.
[29] TER BRAAKE A D, SMIT A E, BOS C, et al. Magnesium prevents vascular calcification in Klotho deficiency [J]. Kidney Int, 2020, 97(3): 487-501.
[30] MATSUZAKI H, KAJITA Y, MIWA M. Magnesium deficiency increases serum fibroblast growth factor-23 levels in rats [J]. Magnes Res, 2013, 26(1): 18-23.
[31] RODRíGUEZ-ORTIZ M E, CANALEJO A, HERENCIA C, et al. Magnesium modulates parathyroid hormone secretion and upregulates parathyroid receptor expression at moderately low calcium concentration [J]. Nephrol Dial Transplant, 2014, 29(2): 282-9.
[32] MONTES DE OCA A, GUERRERO F, MARTINEZ-MORENO J M, et al. Magnesium inhibits Wnt/β-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells [J]. PLoS One, 2014, 9(2): e89525.
[33] SAKAGUCHI Y, HAMANO T, WADA A, et al. Magnesium and Risk of Hip Fracture among Patients Undergoing Hemodialysis [J]. J Am Soc Nephrol, 2018, 29(3): 991-9.
[34] ZAHER M M, ABDEL-SALAM M, ABDEL-SALAM R, et al. Serum magnesium level and vascular stiffness in children with chronic kidney disease on regular hemodialysis [J]. Saudi J Kidney Dis Transpl, 2016, 27(2): 233-40.
[35] SAKAGUCHI Y, HAMANO T, OBI Y, et al. A Randomized Trial of Magnesium Oxide and Oral Carbon Adsorbent for Coronary Artery Calcification in Predialysis CKD [J]. J Am Soc Nephrol, 2019, 30(6): 1073-85.
[36] TZANAKIS I P, STAMATAKI E E, PAPADAKI A N, et al. Magnesium retards the progress of the arterial calcifications in hemodialysis patients: a pilot study [J]. Int Urol Nephrol, 2014, 46(11): 2199-205.
[37] BRESSENDORFF I, HANSEN D, SCHOU M, et al. The Effect of Increasing Dialysate Magnesium on Serum Calcification Propensity in Subjects with End Stage Kidney Disease: A Randomized, Controlled Clinical Trial [J]. Clin J Am Soc Nephrol, 2018, 13(9): 1373-80.
[38] BAI Y, ZHANG J, XU J, et al. Magnesium prevents β-glycerophosphate-induced calcification in rat aortic vascular smooth muscle cells [J]. Biomed Rep, 2015, 3(4): 593-7.
